Related Experiment Videos
[Gene therapy in liver diseases]
Alajos Pár1, Péter László Lakatos, Margit Abonyi
1Altalános Orvostudományi Kar, I. sz. Belgyógyászati Klinika, Pécsi Tudományegyetem, Pécs.
Orvosi Hetilap
|March 9, 2002
Summary
Gene therapy, including ex vivo and in vivo gene transfers, is a promising approach for treating liver diseases like hepatocellular carcinoma. While still in the preclinical stage, ongoing research suggests its future clinical utility in hepatology.
Area of Science:
- Molecular Biology
- Genetics
- Hepatology
Context:
- Gene therapy involves introducing genetic material to treat diseases.
- Ex vivo and in vivo gene transfer methods are key techniques.
- Hepatocellular carcinoma (HCC) is a significant liver disease.
Purpose:
- To review the fundamental principles of gene therapy.
- To examine clinical application models and experimental results for liver diseases, particularly HCC.
- To assess the current preclinical status and future potential of gene therapy in clinical hepatology.
Summary:
- This paper reviews gene therapy principles, including ex vivo and in vivo gene transfer methods and various vectors.
- It presents models for clinical application, highlighting experimental results for liver diseases, especially hepatocellular carcinoma.
- Gene therapy is currently in the preclinical stage but shows future promise for clinical hepatology.
Impact:
- Provides a comprehensive overview of gene therapy for liver disease treatment.
- Highlights the potential of gene therapy in managing hepatocellular carcinoma.
- Predicts gene therapy's future role in clinical hepatology with ongoing research and problem resolution.